含有黄素的血小板与氧基水凝复合系统通过光激活进行有效的血液静止管理和伤口愈合
Xiang-Yi Zhao1, Jing-Yu Lu2, Liang Zheng3
1Shiyan Key Laboratory of Natural Medicine Nanoformulation Research, Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Renmin road No. 30, Shiyan, Hubei 442000, China.
International journal of biological macromolecules
|May 18, 2025
概括
这项研究在水凝中引入光激活的库尔库载有血小板,以增强伤口愈合. 这种新疗法加速组织修复,减少出血,提供了一个有前途的生物制药方法.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 伤口治愈研究研究 伤口治愈研究
背景情况:
- 血小板介导的伤口愈合对于组织修复至关重要.
- 现有的疗法缺乏有针对性的激活和高效的交付.
- 库尔库明和基于血小板的策略显示出治疗潜力.
研究的目的:
- 开发和评估一种用于伤口愈合的新型光激活治疗系统.
- 为了提高疗效,将含有黄素的血小板 (PLT/CUR) 与氧基水凝 (HPCH) 结合起来.
- 研究光激活对血小板功能和伤口修复的机制.
主要方法:
- 使用流动细胞计,共聚焦显微镜和传输电子显微镜进行素载荷血小板 (PLT/CUR) 的表征.
- 在子出血模型和老鼠急性创伤模型中评估PLT/CUR/HPCH疗效.
- 评估光激活对血小板聚合,CD62p/TXA2R表达和血管生成的影响.
主要成果:
- 在不影响活力的前提下,成功将黄素装入血小板.
- 光激活增强了血小板聚合和亲血管性信号传递.
- PLT/CUR/HPCH显著减少出血,表现出抗菌活性,并加速伤口关闭 (53%与对照组<8%在第3天).
结论:
- 光激活PLT/CUR/HPCH是一种高效的伤口愈合生物制药.
- 这种方法为再生医学中针对性血小板激活建立了框架.
- 该研究引入了基于血小板的生物制药在伤口修复中的新应用.
相关概念视频
01:22Formation of the Platelet Plug
3.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.6K
01:05Introduction to Hemostasis
4.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
4.8K
01:09Coagulation
4.0K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.0K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
4.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.6K
01:16Clot Retraction and Fibrinolysis
3.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.2K
01:18Structure and Function of Platelets
940
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
940